Upgrade to SI Premium - Free Trial

Rigel Pharma (RIGL) Misses Q1 EPS by 4c

May 3, 2011 7:37 AM
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) reported Q1 EPS of ($0.40), $0.04 worse than the analyst estimate of ($0.36).

Categories

Earnings